1.
Less veno-occlusive disease after intravenous versus oral busulfan for autologous haematopoietic stem cell transp.l antation: the Belgian paediatric experlence
2.
La drépanocytose : affection exotique ou problème de santé publique en Belgique? ; Sickle cell disease: exotic disease or a Belgian public health problem?
3.
The strategic plan for paediatric cancer treatment and clinical research development in Belgium
Clinical trial preparedness for paediatric medicines development: the Belgian model of clinical trial organisation in paediatric haematology and oncology.
Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.